These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 12444442)

  • 1. Hepatocellular carcinoma in a patient with acromegaly and high serum levels of insulin-like growth factor I: report of a case.
    Yamaguchi M; Tate G; Yoshizawa Y; Midorikawa T; Sanada Y; Kumada K
    Surg Today; 2002; 32(11):1008-11. PubMed ID: 12444442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum insulin-like growth factor I evaluation as a useful tool for predicting the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis: a prospective study.
    Mazziotti G; Sorvillo F; Morisco F; Carbone A; Rotondi M; Stornaiuolo G; Precone DF; Cioffi M; Gaeta GB; Caporaso N; Carella C
    Cancer; 2002 Dec; 95(12):2539-45. PubMed ID: 12467068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radioimmunoassay of serum IGF-I and IGF-II in patients with chronic liver diseases and hepatocellular carcinoma with or without hypoglycemia.
    Wu JC; Daughaday WH; Lee SD; Hsiao TS; Chou CK; Lin HD; Tsai YT; Chiang BN
    J Lab Clin Med; 1988 Nov; 112(5):589-94. PubMed ID: 2460570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible contribution of serum activin A and IGF-1 in the development of hepatocellular carcinoma in Egyptian patients suffering from combined hepatitis C virus infection and hepatic schistosomiasis.
    Elsammak MY; Amin GM; Khalil GM; Ragab WS; Abaza MM
    Clin Biochem; 2006 Jun; 39(6):623-9. PubMed ID: 16624274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating growth hormone and insulin-like growth factor-I in nonalcoholic liver cirrhosis with or without superimposed hepatocarcinoma: evidence of an altered circadian rhythm.
    Buzzelli G; Dattolo P; Pinzani M; Brocchi A; Romano S; Gentilini P
    Am J Gastroenterol; 1993 Oct; 88(10):1744-8. PubMed ID: 8213718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple bronchioloalveolar carcinomas in acromegaly: a potential role of insulin-like growth factor I in carcinogenesis.
    Motoi N; Kishi K; Fujii T; Tsuboi E; Ohashi K; Yoshimura K
    Lung Cancer; 2006 Nov; 54(2):247-53. PubMed ID: 16942817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hepatocellular carcinoma complicated by non-islet cell tumor hypoglycemia].
    van Wijngaarden P; Janssen JA; de Man RA
    Ned Tijdschr Geneeskd; 2002 May; 146(18):859-62. PubMed ID: 12038225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of combined hepatocellular and cholangiocarcinoma showing tumor growth and invasion to the diaphragm during interferon-alpha and 5-fluorouracil combined intra-arterial chemotherapy].
    Noda T; Nagano H; Marubashi S; Kobayashi S; Takeda Y; Murakami M; Tomimaru Y; Dono K; Umeshita K; Nakayama M; Shima T; Wakasa K; Monden M; Doki Y; Mori M
    Gan To Kagaku Ryoho; 2008 Nov; 35(12):2099-102. PubMed ID: 19106536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Locoregional recurrences are frequent after radiofrequency ablation for hepatocellular carcinoma.
    Harrison LE; Koneru B; Baramipour P; Fisher A; Barone A; Wilson D; Dela Torre A; Cho KC; Contractor D; Korogodsky M
    J Am Coll Surg; 2003 Nov; 197(5):759-64. PubMed ID: 14585410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum IGF-1, IGF-2 and IGFBP-3 as parameters in the assessment of liver dysfunction in patients with hepatic cirrhosis and in the diagnosis of hepatocellular carcinoma.
    Rehem RN; El-Shikh WM
    Hepatogastroenterology; 2011; 58(107-108):949-54. PubMed ID: 21830422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of colorectal lesions by using autofluorescence colonoscopy in acromegalics and their relation to serum growth hormone and insulin-like growth factor-1 levels.
    Matyja V; Kos-Kudla B; Foltyn W; Strzelczyk J; Latos W; Marek B; Kajdaniuk D; Karpe J; Ostrowska Z; Sieron-Stoltny K; Sieron A
    Neuro Endocrinol Lett; 2006 Oct; 27(5):639-43. PubMed ID: 17159821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased IGF-I : IGFBP-3 ratio in patients with hepatocellular carcinoma.
    Mattera D; Capuano G; Colao A; Pivonello R; Manguso F; Puzziello A; D'Agostino L
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):699-706. PubMed ID: 14974910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
    Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ
    J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum alpha-fetoprotein level per tumor volume reflects prognosis in patients with hepatocellular carcinoma after curative hepatectomy.
    Furihata T; Sawada T; Kita J; Iso Y; Kato M; Rokkaku K; Shimoda M; Kubota K
    Hepatogastroenterology; 2008; 55(86-87):1705-9. PubMed ID: 19102374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of serum hepatocyte growth factor levels in patients with hepatocellular carcinoma undergoing hepatic resection.
    Chau GY; Lui WY; Chi CW; Chau YP; Li AF; Kao HL; Wu CW
    Eur J Surg Oncol; 2008 Mar; 34(3):333-8. PubMed ID: 17218078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High expression of insulin-like growth factor binding protein-3 is correlated with lower portal invasion and better prognosis in human hepatocellular carcinoma.
    Aishima S; Basaki Y; Oda Y; Kuroda Y; Nishihara Y; Taguchi K; Taketomi A; Maehara Y; Hosoi F; Maruyama Y; Fotovati A; Oie S; Ono M; Ueno T; Sata M; Yano H; Kojiro M; Kuwano M; Tsuneyoshi M
    Cancer Sci; 2006 Nov; 97(11):1182-90. PubMed ID: 16965600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normal insulin-like growth factor-I in an elderly woman with acromegaly and medical illness.
    Jaffe LS; Rosen HN
    Arch Intern Med; 1994 Jul; 154(13):1533-5. PubMed ID: 8018009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High serum vascular endothelial growth factor levels predict poor prognosis after radiofrequency ablation of hepatocellular carcinoma: importance of tumor biomarker in ablative therapies.
    Poon RT; Lau C; Pang R; Ng KK; Yuen J; Fan ST
    Ann Surg Oncol; 2007 Jun; 14(6):1835-45. PubMed ID: 17406950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study on the prognostic value of hepatocyte growth factor and c-met for patients with hepatocellular carcinoma].
    Wu FS; Zheng SS; Wu LJ; Ding W; Ma ZM; Wang ZM; Teng LS; Zhao WH
    Zhonghua Wai Ke Za Zhi; 2006 May; 44(9):603-8. PubMed ID: 16784653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrence of hepatitis B-related hepatocellular carcinoma is associated with high viral load at the time of resection.
    Hung IF; Poon RT; Lai CL; Fung J; Fan ST; Yuen MF
    Am J Gastroenterol; 2008 Jul; 103(7):1663-73. PubMed ID: 18616655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.